Summary:
Investigation of the clinical effect of Active Hexose Correlated Compound (AHCC) on chronic fatigue syndrome (CFS) patients.
Qualified Participants Must:
• Be between the ages of 21 and 60
• Have been given definitive diagnosis by doctor
• The patients who are consent to participate in the study and ingest AHCC
• Understand the significance, procedure and aim of the study, and give consent in writing
NOT be:
(1) Obese patients (BMI > 40)
(2) Patients with primary sleep disorder
(3) Patients with mental disorder
(4) Patients who are determined to be unsuitable by doctor
Qualified Participants May Receive:
Patients will receive a compensation based on the amount of time they actively spend on the study.